Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer

    Metastasis occurs frequently after resection of pancreatic cancer (PaC). In this study, we hypothesized that multi-parametric analysis of pre-metastatic liver biopsies would classify patients according to thei...

    Linda Bojmar, Constantinos P. Zambirinis, Jonathan M. Hernandez in Nature Medicine (2024)

  2. Article

    Open Access

    Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial

    Pancreatic and colorectal cancers are often KRAS mutated and are incurable when tumor DNA or protein persists or recurs after curative intent therapy. Cancer vaccine ELI-002 2P enhances lymph node delivery and...

    Shubham Pant, Zev A. Wainberg, Colin D. Weekes, Muhammad Furqan in Nature Medicine (2024)

  3. Article

    Open Access

    Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

    Pancreatic ductal adenocarcinoma (PDAC) is lethal in 88% of patients1, yet harbours mutation-derived T cell neoantigens that are suitable for vaccines 2,3. Here in a phase I trial of adjuvant autogene cevumeran, ...

    Luis A. Rojas, Zachary Sethna, Kevin C. Soares, Cristina Olcese, Nan Pang in Nature (2023)

  4. No Access

    Article

    Reappraisal of T1b gallbladder cancer (GBC): clinicopathologic analysis of 473 in situ and invasive GBCs and critical review of the literature highlights its rarity, and that it has a very good prognosis

    There are highly conflicting data on relative frequency (2–32%), prognosis, and management of pT1b-gallbladder carcinoma (GBC), with 5-year survival ranging from > 90% in East/Chile where cholecystectomy is re...

    Burcin Pehlivanoglu, Gizem Akkas, Bahar Memis, Olca Basturk in Virchows Archiv (2023)

  5. Article

    Open Access

    Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations

    Traditional genetic testing for patients with gastrointestinal stromal tumors (GISTs) focus on those with syndromic features. To assess whether expanded genetic testing of GIST patients could identify heredita...

    Diana Mandelker, Antonio Marra, Nikita Mehta, Pier Selenica in npj Precision Oncology (2023)

  6. No Access

    Article

    Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

    In this review, we detail the changes and the relevant features that are applied to neuroendocrine neoplasms (NENs) in the 2022 WHO Classification of Endocrine and Neuroendocrine Tumors. Using a question-and-a...

    Guido Rindi, Ozgur Mete, Silvia Uccella, Olca Basturk in Endocrine Pathology (2022)

  7. No Access

    Article

    T2 gallbladder cancer shows substantial survival variation between continents and this is not due to histopathologic criteria or pathologic sampling differences

    Published data on survival of T2 gallbladder carcinoma (GBC) from different countries show a wide range of 5-year survival rates from 30–> 70%. Recently, studies have demonstrated substantial variation between...

    Mia S. DeSimone, Michael Goodman, Burcin Pehlivanoglu, Bahar Memis in Virchows Archiv (2021)

  8. Article

    Open Access

    Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma

    Herein, we investigate the relationship between pancreatic stem cell markers (PCSC markers), CD44, and epithelial-specific antigen (ESA), tumor stroma, and the impact on recurrence outcomes in pancreatic ducta...

    Gokce Askan, Ibrahim Halil. Sahin, Joanne F. Chou, Aslihan Yavas in BMC Cancer (2021)

  9. No Access

    Article

    Ectopic Thyroid in the Common Bile Duct: First Case Report

    Begum Yeni, William R. Jarnagin, Olca Basturk in Journal of Gastrointestinal Cancer (2021)

  10. No Access

    Article

    Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors

    Well differentiated neuroendocrine tumors (NETs) arising in the gastrointestinal and pancreaticobiliary system are the most common neuroendocrine neoplasms. Studies of the molecular basis of these lesions have...

    Sylvia L. Asa, Stefano La Rosa, Olca Basturk, Volkan Adsay in Endocrine Pathology (2021)

  11. No Access

    Article

    Intracholecystic tubular non-mucinous neoplasm (ICTN) of the gallbladder: a clinicopathologically distinct, invasion-resistant entity

    Preinvasive tumor-forming gallbladder neoplasms that are composed of small, non-mucinous tubules with complex architecture remain a poorly characterized group. Here, we evaluated the clinicopathological charac...

    Burcin Pehlivanoglu, Serdar Balci, Olca Basturk, Pelin Bagci in Virchows Archiv (2021)

  12. No Access

    Article

    Morphologic Variants of Pancreatic Neuroendocrine Tumors: Clinicopathologic Analysis and Prognostic Stratification

    Better prognostication/stratification of pancreatic neuroendocrine tumors (PanNETs) is needed. In this detailed morpheomic study of 163 resected PanNETs, 11 unusual variants, some of which were not previously ...

    Yue Xue, Michelle D. Reid, Burcin Pehlivanoglu, Rebecca C. Obeng in Endocrine Pathology (2020)

  13. No Access

    Article

    A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma

    Pancreatic cancer expression profiles largely reflect a classical or basal-like phenotype. The extent to which these profiles vary within a patient is unknown. We integrated evolutionary analysis and expressio...

    Akimasa Hayashi, Jun Fan, Ruoyao Chen, Yu-jui Ho, Alvin P. Makohon-Moore in Nature Cancer (2020)

  14. No Access

    Article

    Clear Cell Sarcoma-Like Tumor of the Gastrointestinal Tract

    Gokce Askan, Faruk Erdem Kombak, Ipek Erbarut Seven in Journal of Gastrointestinal Cancer (2019)

  15. No Access

    Article

    CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma

    The aim of this study was to investigate the relationship between CT imaging phenotypes and genetic and biological characteristics in pancreatic ductal adenocarcinoma (PDAC).

    Marc A. Attiyeh, Jayasree Chakraborty, Caitlin A. McIntyre in Abdominal Radiology (2019)

  16. No Access

    Article

    Sarcomatoid carcinomas of the gallbladder: clinicopathologic characteristics

    Sarcomatoid carcinomas recently came into the spotlight through genetic profiling studies and also as a distinct model of epithelial–mesenchymal transition. The literature on sarcomatoid carcinomas of gallblad...

    Orhun Cig Taskin, Gizem Akkas, Bahar Memis, Ipek Erbarut Seven in Virchows Archiv (2019)

  17. No Access

    Article

    Immunohistochemical null-phenotype for mismatch repair proteins in colonic carcinoma associated with concurrent MLH1 hypermethylation and MSH2 somatic mutations

    Microsatellite instability, a well-established driver pathway in colorectal carcinogenesis, can develop in both sporadic and hereditary conditions via different molecular alterations in the DNA mismatch repair...

    Tao Wang, Zsofia K. Stadler, Liying Zhang, Martin R. Weiser in Familial Cancer (2018)

  18. No Access

    Reference Work Entry In depth

    Pathologic Classification and Biological Behavior of Pancreatic Neoplasia

    Pancreatic neoplasms are classified according to the normal cells they recapitulate. These neoplasms’ clinicopathologic and biologic characteristics are determined mostly by their cellular lineage. Most are of...

    Olca Basturk, Michelle D. Reid, N. Volkan Adsay in Pancreatic Cancer (2018)

  19. No Access

    Article

    Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer

    The analysis of T-cell antigens in long-term survivors of pancreatic ductal adenocarcinoma suggests that neoantigen immunogenicity and quality, not purely quantity, correlate with survival.

    Vinod P. Balachandran, Marta Łuksza, Julia N. Zhao, Vladimir Makarov in Nature (2017)

  20. No Access

    Article

    Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies

    Re-operation is advised for patients with T1b or greater incidental gallbladder cancer (GBCA). The presence of residual disease (RD) impacts resectability, chemotherapy, and survival. This study created a preo...

    John M. Creasy, Debra A. Goldman, Mithat Gonen in Journal of Gastrointestinal Surgery (2017)

previous disabled Page of 2